Unicycive Therapeutics, Inc. - Common Stock

Share · US90466Y1038 · UNCY (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

19.12.2025 17:27

Current Prices from Unicycive Therapeutics, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	UNCY	USD	19.12.2025 17:31	5,48 USD	0,07 USD +1,20 %

Share Float & Liquidity

Free Float 73,65 %

Shares Float 13,01 M

Shares Outstanding 17,66 M

Company Profile for Unicycive Therapeutics, Inc. - Common Stock Share

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.

Get up to date insights from finAgent about Unicycive Therapeutics, Inc. - Common Stock

Company Data

Name Unicycive Therapeutics, Inc. - Common Stock

Company Unicycive Therapeutics, Inc.

Symbol UNCY

Website https://www.unicycive.com

Primary Exchange

NASDAQ

ISIN US90466Y1038

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Shalabh K. Gupta MPA

Market Capitalization 100 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 4300 El Camino Real, 94022 Los Altos

IPO Date 2021-07-12

Stock Splits

Date	Split
20.06.2025	1:10

Ticker Symbols

Name	Symbol
NASDAQ	UNCY

More Shares

Investors who hold Unicycive Therapeutics, Inc. - Common Stock also have the following shares in their portfolio:

BANGKOK BK 25/35 REGS Bond

J-Star Holding Co., Ltd. - Ordinary Shares Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog